內地去年電影票房逾549億人幣 今年元旦檔票房刷新影史紀錄
國家電影局公佈2023年中國電影行業重要指標顯示,2023年全年電影票房爲549.15億元人民幣(下同),其中國產影片票房爲460.05億元,佔比83.77%;城市院線觀影人次12.99億。全年票房過億元影片共73部,其中國產影片50部,票房排名首十位均爲國產影片。
另外,據貓眼專業版數據顯示,2023年元旦檔(12月30日至1月1日)總票房突破13.11億元,超過2021年元旦檔13.03億元票房成績,刷新內地影史元旦檔票房紀錄。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.